# Max Marchione - Peptides, Pharma 2.0, and why Hims could 10x or even 100x 🤯

Page: https://stenobird.com/podcast/hims-house-7026583/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x
Text version: https://stenobird.com/podcast/hims-house-7026583/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x.md
Podcast: [Hims House](https://stenobird.com/podcast/hims-house-7026583)
Published: 2026-02-06T12:36:36+00:00
Episode link: https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Max-Marchione---Peptides--Pharma-2-0--and-why-Hims-could-10x-or-even-100x-e3en03q
Audio file: https://anchor.fm/s/10e9c0874/podcast/play/115097146/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-6%2F417560179-44100-2-b034900e62f76.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x
Duration seconds: 2971

## Resource

Thanks to our partner, Mochi Health! https://JoinMochi.com Subscribe to Hims House: https://himshouse.com/subscribe Follow us: https://x.com/himshouse https://x.com/jonathanrstern https://x.com/maxmarchione Join the Discord: https://discord.gg/tJqGgVhkEt In this episode of Hims House, Jonathan Stern sits down with Max Marchione (Founder/CEO of Superpower) to break down what Hims' “rich people live longer” Super Bowl ad signals about the company’s ambitions beyond GLP-1s. They debate the path from DTC e-commerce to a true health platform -- membership, verticalized manufacturing, and “Pharma 2.0” wellness therapeutics -- then widen to the peptide boom, gray-market demand, and the “health super app” race. They close on labs pricing dynamics, AI hiring, and what could re-rate Hims’ valuation. 00:00 – Sponsor: Mochi Health 01:58 – Why Hims' Super Bowl ad works 03:52 – Membership + manufacturing + pharma 2.0 06:33 – Superpower's approach 10:19 – The peptide market explosion + retatrutide 16:13 – Health "super-app" race: Hims, Whoop, Oura, Superpower 19:50 – Deep dive into peptides and regulatory outlook 27:50 – Superpower's product roadmap 28:39 – Pharma 2.0 and consumer-driven wellness 30:25 – Labs pricing strategies and market dynamics 36:51 – AI and engineering: what is Hims building?! 42:25 – Hims valuation: 10x (or even 100x) potential 🤯 47:27 – Future of GLP-1s Not financial, legal, or medical advice

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/hims-house-7026583/max-marchione-peptides-pharma-2-0-and-why-hims-could-10x-or-even-100x.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.